Cargando…
IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity
Previous mouse and clinical studies demonstrate a link between Th2 intestinal inflammation and induction of the effector phase of food allergy. However, the mechanism by which sensitization and mast cell responses occurs is largely unknown. We demonstrate that interleukin (IL)-9 has an important rol...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292227/ https://www.ncbi.nlm.nih.gov/pubmed/18378796 http://dx.doi.org/10.1084/jem.20071046 |
_version_ | 1782152488860778496 |
---|---|
author | Forbes, Elizabeth E. Groschwitz, Katherine Abonia, J. Pablo Brandt, Eric B. Cohen, Elizabeth Blanchard, Carine Ahrens, Richard Seidu, Luqman McKenzie, Andrew Strait, Richard Finkelman, Fred D. Foster, Paul S. Matthaei, Klaus I. Rothenberg, Marc E. Hogan, Simon P. |
author_facet | Forbes, Elizabeth E. Groschwitz, Katherine Abonia, J. Pablo Brandt, Eric B. Cohen, Elizabeth Blanchard, Carine Ahrens, Richard Seidu, Luqman McKenzie, Andrew Strait, Richard Finkelman, Fred D. Foster, Paul S. Matthaei, Klaus I. Rothenberg, Marc E. Hogan, Simon P. |
author_sort | Forbes, Elizabeth E. |
collection | PubMed |
description | Previous mouse and clinical studies demonstrate a link between Th2 intestinal inflammation and induction of the effector phase of food allergy. However, the mechanism by which sensitization and mast cell responses occurs is largely unknown. We demonstrate that interleukin (IL)-9 has an important role in this process. IL-9–deficient mice fail to develop experimental oral antigen–induced intestinal anaphylaxis, and intestinal IL-9 overexpression induces an intestinal anaphylaxis phenotype (intestinal mastocytosis, intestinal permeability, and intravascular leakage). In addition, intestinal IL-9 overexpression predisposes to oral antigen sensitization, which requires mast cells and increased intestinal permeability. These observations demonstrate a central role for IL-9 and mast cells in experimental intestinal permeability in oral antigen sensitization and suggest that IL-9–mediated mast cell responses have an important role in food allergy. |
format | Text |
id | pubmed-2292227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-22922272008-10-14 IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity Forbes, Elizabeth E. Groschwitz, Katherine Abonia, J. Pablo Brandt, Eric B. Cohen, Elizabeth Blanchard, Carine Ahrens, Richard Seidu, Luqman McKenzie, Andrew Strait, Richard Finkelman, Fred D. Foster, Paul S. Matthaei, Klaus I. Rothenberg, Marc E. Hogan, Simon P. J Exp Med Articles Previous mouse and clinical studies demonstrate a link between Th2 intestinal inflammation and induction of the effector phase of food allergy. However, the mechanism by which sensitization and mast cell responses occurs is largely unknown. We demonstrate that interleukin (IL)-9 has an important role in this process. IL-9–deficient mice fail to develop experimental oral antigen–induced intestinal anaphylaxis, and intestinal IL-9 overexpression induces an intestinal anaphylaxis phenotype (intestinal mastocytosis, intestinal permeability, and intravascular leakage). In addition, intestinal IL-9 overexpression predisposes to oral antigen sensitization, which requires mast cells and increased intestinal permeability. These observations demonstrate a central role for IL-9 and mast cells in experimental intestinal permeability in oral antigen sensitization and suggest that IL-9–mediated mast cell responses have an important role in food allergy. The Rockefeller University Press 2008-04-14 /pmc/articles/PMC2292227/ /pubmed/18378796 http://dx.doi.org/10.1084/jem.20071046 Text en Copyright © 2008, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Forbes, Elizabeth E. Groschwitz, Katherine Abonia, J. Pablo Brandt, Eric B. Cohen, Elizabeth Blanchard, Carine Ahrens, Richard Seidu, Luqman McKenzie, Andrew Strait, Richard Finkelman, Fred D. Foster, Paul S. Matthaei, Klaus I. Rothenberg, Marc E. Hogan, Simon P. IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity |
title | IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity |
title_full | IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity |
title_fullStr | IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity |
title_full_unstemmed | IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity |
title_short | IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity |
title_sort | il-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivity |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2292227/ https://www.ncbi.nlm.nih.gov/pubmed/18378796 http://dx.doi.org/10.1084/jem.20071046 |
work_keys_str_mv | AT forbeselizabethe il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT groschwitzkatherine il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT aboniajpablo il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT brandtericb il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT cohenelizabeth il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT blanchardcarine il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT ahrensrichard il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT seiduluqman il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT mckenzieandrew il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT straitrichard il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT finkelmanfredd il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT fosterpauls il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT matthaeiklausi il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT rothenbergmarce il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity AT hogansimonp il9andmastcellmediatedintestinalpermeabilitypredisposestooralantigenhypersensitivity |